The Korean Journal of Medicine

  • 제82권2호
  • /
  • Pages.175-184
  • /
  • 2012
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

관상동맥 중재술을 시행 받은 40세 이하의 ST 분절 상승과 비상승 심근경색증 환자의 예후 비교

Comparison of Clinical Outcomes between ST-Segment Elevation Myocardial Infarction and Non-ST-Segment Elevation Myocardial Infarction in Patients Younger Than 40 Years Who Underwent Percutaneous Coronary Artery Intervention

  • 김남윤 (전남대학교병원 심장센터) ;
  • 박인혜 (전남대학교 간호대학) ;
  • 정명호 (전남대학교병원 심장센터) ;
  • 이숙자 (전남대학교병원 간호부) ;
  • 김동한 (전남대학교병원 심장센터) ;
  • 이기홍 (전남대학교병원 심장센터) ;
  • 이민구 (전남대학교병원 심장센터) ;
  • 심두선 (전남대학교병원 심장센터) ;
  • 박근호 (전남대학교병원 심장센터) ;
  • 윤남식 (전남대학교병원 심장센터) ;
  • 윤현주 (전남대학교병원 심장센터) ;
  • 김계훈 (전남대학교병원 심장센터) ;
  • 홍영준 (전남대학교병원 심장센터) ;
  • 김주한 (전남대학교병원 심장센터) ;
  • 안영근 (전남대학교병원 심장센터) ;
  • 조정관 (전남대학교병원 심장센터) ;
  • 박종춘 (전남대학교병원 심장센터) ;
  • 강정채 (전남대학교병원 심장센터)
  • Kim, Nam-Yoon (The Heart Center of Chonnam National University Hospital) ;
  • Park, In-Hyae (Nursing College of Chonnam National Univeristy) ;
  • Jeong, Myung-Ho (The Heart Center of Chonnam National University Hospital) ;
  • Lee, Sook-Ja (Department of Nursing, Chonnam National University Hospital) ;
  • Kim, Dong-Han (The Heart Center of Chonnam National University Hospital) ;
  • Lee, Gi-Hong (The Heart Center of Chonnam National University Hospital) ;
  • Lee, Min-Goo (The Heart Center of Chonnam National University Hospital) ;
  • Sim, Doo-Sun (The Heart Center of Chonnam National University Hospital) ;
  • Park, Keun-Ho (The Heart Center of Chonnam National University Hospital) ;
  • Yoon, Nam-Sik (The Heart Center of Chonnam National University Hospital) ;
  • Yoon, Hyun-Ju (The Heart Center of Chonnam National University Hospital) ;
  • Kim, Kye-Hun (The Heart Center of Chonnam National University Hospital) ;
  • Hong, Young-Joon (The Heart Center of Chonnam National University Hospital) ;
  • Kim, Ju-Han (The Heart Center of Chonnam National University Hospital) ;
  • Ahn, Young-Keun (The Heart Center of Chonnam National University Hospital) ;
  • Cho, Jeong-Gwan (The Heart Center of Chonnam National University Hospital) ;
  • Park, Jong-Chun (The Heart Center of Chonnam National University Hospital) ;
  • Kang, Jung-Chaee (The Heart Center of Chonnam National University Hospital)
  • 발행 : 2012.02.01
⟨ 이전 논문 다음 논문 ⟩

초록

목적: 최근 흡연의 증가, 식이습관 변화 등 생활양식의 변화로 젊은 연령의 급성 심근경색증 환자가 급격히 증가하고 있는 추세이다. 하지만 젊은 급성 심근경색증 환자의 ST 분절 상승 여부에 따른 장기 예후에 대한 연구가 부족하다. 방법: 급성 심근경색증 진단하에 성공적인 경피적 관상동맥 중재술(percutaneous coronary intervention, PCI)을 시술 받은 40세 이하의 환자 164명을 대상으로 하였다. ST 분절 상승 심근경색증(ST-elevation myocardial infarction, STEMI 120명)과 ST 분절 비상승 심근경색증(non-ST-elevation myocardial infarction, NSTEMI; 44명)로 나누어 두 군 간의 임상적 특징 및 주요 심장사건(사망, 재 경색증, 표적 병변 재개통술, 관상동맥 우회술)을 비교하였다. 결과: ST 분절 상승 심근경색증군에서 ST 분절 비상승 심근경색증군보다 내원 시 troponin-I 수치가 높았으며(66.9 ${\pm}$ 103.6 ng/mL vs. 26.6 ${\pm}$ 38.5 ng/mL, p = 0.014), N-terminal pro-brain natriuretic peptide (733.0 ${\pm}$ 1,018.1 pg/mL vs. 476.2 ${\pm}$ 374.5 pg/mL, p = 0.012)도 높았다. ST 분절 비상승 심근경색증군에서 ST 분절 상승 심근경색증군보다 Killip class II에 해당하는 환자가 많았고(5.8% vs. 15.9%, p = 0.041), 혈청 크레아틴(0.9 ${\pm}$ 0.2 mg/dL vs. 1.3 ${\pm}$ 2.0 mg/dL, p = 0.001)도 높았다. 1년 동안 발생한 주요 심장사건은 두 군 간에 차이는 없었고, 다변량 분석에서 전체 환자의 주요 심장사건을 유의하게 예측하는 인자는 일반금속 스텐트의 삽입(odds ratio 3.360, 95% confidence interval 1.105 to 10.217, p = 0.033), 높은 lipoprotein (a) 수치 (odds ratio 1.047, 95% confidence interval 1.020 to 1.075, p = 0.001) 등이었다. 결론: 40세 이하의 젊은 급성 심근경색증 환자에서 ST 분절 상승 심근경색증과 ST 분절 비상승 심근경색증 환자간 예후는 차이가 없었고, 주요 심장사건에 영향을 미치는 인자로는 일반금속 스텐트 삽입과 혈청 lipotrotein (a) 수치이었다.

Background/Aims: The prevalence of coronary artery disease has increased in young adults. We evaluated the differences in clinical characteristics and clinical outcomes in young patients with ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI). Methods: A total of 164 patients with acute myocardial infarction who underwent percutaneous coronary intervention were divided into two groups: the STEMI group (120 patients; mean age, 35.7 ${\pm}$ 3.8 years; 118 males) and the NSTEMII group (44 patients; mean age, 35.7 ${\pm}$ 4.3 years; 43 males). We analyzed clinical and angiographic characteristics and major adverse cardiac events (MACE), including death from any cause, non-fatal myocardial infarction, target lesion revascularization, and coronary artery bypass graft surgery, during a 1-year clinical follow-up of the two groups. Results: During hospitalization, Killip class II acute myocardial infarction (5.8% vs. 15.9%, p = 0.041) was observed more frequently in the NSTEMI group. The levels of troponin-I (66.9 ${\pm}$ 103.6 vs. 26.6 ${\pm}$ 38.5 ng/mL, p = 0.014) and N-terminal pro-brain natriuretic peptide (733.0 ${\pm}$ 1,018.1 vs. 476.2 ${\pm}$ 374.5 pg/mL, p = 0.012) were significantly higher in the STEMI group. One-year MACE did not differ between the two groups. By multiple logistic regression analysis, bare metal stents (odds ratio, 3.360; 95% confidence interval, 1.105-10.217; p = 0.033) and high lipoprotein (a) levels (odds ratio, 1.047; 95% confidence interval, 1.020-1.075; p = 0.001) were independent predictors of 1-year MACE. Conclusions: Young patients with STEMI and NSTEMI have similar clinical outcomes. Bare metal stents and high serum lipoprotein (a) levels are independent predictors of MACE during 1-year clinical follow-ups in young patients with acute myocardial infarction.

키워드

참고문헌

  1. Doughty M, Mehta R, Bruckman D, et al. Acute myocardial infarction in the young: the University of Michigan experience. Am Heart J 2002;143:56-62. https://doi.org/10.1067/mhj.2002.120300
  2. Fournier JA, Sánchez A, Quero J, Fernández-Cortacero JA, González-Barrero A. Myocardial infarction in men aged 40 years or less: a prospective clinical-angiographic study. Clin Cardiol 1996;19:631-636. https://doi.org/10.1002/clc.4960190809
  3. Moccetti T, Malacrida R, Pasotti E, et al. Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction: data from the GISSI-2 database: investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). Arch Intern Med 1997;157:865-869. https://doi.org/10.1001/archinte.1997.00440290049005
  4. Shiraishi J, Kohno Y, Yamaguchi S, et al. Acute myocardial infarction in young Japanese adults. Circ J 2005;69:1454-1458. https://doi.org/10.1253/circj.69.1454
  5. Trzos E, Uznańska B, Rechciński T, Krzemińska-Pakuła M, Bugała M, Kurpesa M. Myocardial infarction in young people. Cardiol J 2009;16:307-311.
  6. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967;20:457-464. https://doi.org/10.1016/0002-9149(67)90023-9
  7. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography: areport of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography): developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardol 1999;33:1756-1824. https://doi.org/10.1016/S0735-1097(99)00126-6
  8. Kini AS. Coronary angiography, lesion classification and severity assessment. Cardiol Clin 2006;24:153-162. https://doi.org/10.1016/j.ccl.2006.04.002
  9. Roe MT, Ohman EM, Pollack CV Jr, et al. Changing the model of care for patients with acute coronary syndromes. Am Heart J 2003;146:605-612. https://doi.org/10.1016/S0002-8703(03)00388-0
  10. Nikus KC, Eskola MJ, Virtanen VK, et al. Mortality of patients with acute coronary syndromes still remains high: a follow-up study of 1188 consecutive patients admitted to a university hospital. Ann Med 2007;39:63-71. https://doi.org/10.1080/08037060600997534
  11. Song YB, Hahn JY, Kim JH, et al. Comparison of angiographic and other findings and mortality in non-ST-segment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention. Am J Cardiol 2010;106:1397-1403. https://doi.org/10.1016/j.amjcard.2010.07.010
  12. Montalescot G, Dallongeville J, Van Belle E, et al. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 2007;28:1409-1417.
  13. Sim DS, Kim JH, Jeong MH. Differences in clinical outcomes between patients with ST-elevation versus non- ST-elevation acute myocardial infarction in Korea. Korean Circ J 2009;39:297-303. https://doi.org/10.4070/kcj.2009.39.8.297
  14. Medina HM, Cannon CP, Zhao X, et al. Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older: findings from Get With The Guidelines- Coronary Artery Disease (GWTG-CAD). Am Heart J 2011; 162:283-290. https://doi.org/10.1016/j.ahj.2011.04.017
  15. Morillas P, Bertomeu V, Pabon P, et al. Characteristics and outcome of acute myocardial infarction in young patients. The PRIAMHO II study. Cardiology 2007;107:217-225. https://doi.org/10.1159/000095421
  16. Cho JY, Jeong MH, Ahn Y, et al. Predictive factors of major adverse cardiac events and clinical outcomes of acute myocardial infarction in young Korean patients. Korean Circ J 2008;38:161-169. https://doi.org/10.4070/kcj.2008.38.3.161
  17. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/ WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-2538. https://doi.org/10.1093/eurheartj/ehm355
  18. Castelli WP. Cardiovascular disease and multifactorial risk: challenge of the 1980s. Am Heart J 1983;106(5 Pt 2): 1191-1200. https://doi.org/10.1016/0002-8703(83)90174-6
  19. Skelding KA, Mehta LS, Pica MC, et al. Primary percutaneous interventions for acute myocardial infarction in octogenarians: a single-center experience. Clin Cardiol 2002;25:363-366. https://doi.org/10.1002/clc.4950250804
  20. Sakai K, Nakagawa Y, Kimura T, et al. Comparison of results of coronary angioplasty for acute myocardial infarction in patients > or =75 years of age versus patients <75 years of age. Am J Cardiol 2002;89:797-800. https://doi.org/10.1016/S0002-9149(02)02187-2
  21. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81. https://doi.org/10.1038/332078a0
  22. Kwon TG, Bae JH, Jeong MH, et al. N-terminal pro-Btypenatriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Int J Cardiol 2009;133:173-178. https://doi.org/10.1016/j.ijcard.2007.12.022
  23. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N Engl J Med 1994; 331:496-501. https://doi.org/10.1056/NEJM199408253310802
  24. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation 2005;111:2257-2273. https://doi.org/10.1161/01.CIR.0000163587.36485.A7
  25. Nordmann AJ, Hengstler P, Harr T, Young J, Bucher HC. Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a metaanalysis of randomized controlled trials. Am J Med 2004; 116:253-262. https://doi.org/10.1016/j.amjmed.2003.08.035
  26. Hong YJ, Jeong MH, Choi YH, et al. Differences in intravascular ultrasound findings in culprit lesions in infarct-related arteries between ST segment elevation myocardial infarction and non-ST segment elevation myocardial infarction. J Cardiol 2010;56:15-22. https://doi.org/10.1016/j.jjcc.2010.01.010
  27. Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxeleluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006;355:1105-1113. https://doi.org/10.1056/NEJMoa062598
  28. Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 2005;293:2109-2117. https://doi.org/10.1001/jama.293.17.2109
  29. Berg K. A new serum type system in main: the LP System. Acta Pathol Microbiol Scand 1963;59:369-382.
  30. Barre DE. The molecular nature and consequences of lipoprotein (a)'s association with platelets. Protein Pept Lett 2007;14:839-842. https://doi.org/10.2174/092986607782110202
  31. Cho JY, Jeong MH, Ahn Y, et al. High lipoprotein(a) levels are associated with long-term adverse outcomes in acute myocardial infarction patients in high Killip classes. Korean Circ J 2010;40:491-498. https://doi.org/10.4070/kcj.2010.40.10.491

피인용 문헌

  1. Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction vol.8, pp.4, 2012, https://doi.org/10.24171/j.phrp.2017.8.4.02
  2. Prognostic role of NT-proBNP (N-terminal pro-brain natriuretic peptide) in patients with non-ST-segment elevation myocardial infarction: analysis based on propensity score matching and weighting vol.18, pp.3, 2012, https://doi.org/10.12729/jbtr.2017.18.3.067